2023
DOI: 10.1186/s13054-023-04526-2
|View full text |Cite
|
Sign up to set email alerts
|

Extended prone positioning for intubated ARDS: a review

Abstract: During the COVID-19 pandemic, several centers had independently reported extending prone positioning beyond 24 h. Most of these centers reported maintaining patients in prone position until significant clinical improvement was achieved. One center reported extending prone positioning for organizational reasons relying on a predetermined fixed duration. A recent study argued that a clinically driven extension of prone positioning beyond 24 h could be associated with reduced mortality. On a patient level, the ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 51 publications
0
1
0
Order By: Relevance
“…However, in a recent study, PP sessions lasting 24 h or more and implemented in patients with PaO 2 /FiO 2 ratio greater than 150 mmHg were associated with increased survival in COVID-19 related ARDS [ 7 ]. It was therefore recently suggested that a longer duration of prone therapy may further improve ARDS patients’ outcome, but additional data with longer PP duration of PP are still awaited [ 8 ]. Moreover, PP increases the workload of ICU staff and is associated with certain risks, including pressure sores, potential hindrance to enteral nutrition and a higher rate of catheter-related blood stream infection [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, in a recent study, PP sessions lasting 24 h or more and implemented in patients with PaO 2 /FiO 2 ratio greater than 150 mmHg were associated with increased survival in COVID-19 related ARDS [ 7 ]. It was therefore recently suggested that a longer duration of prone therapy may further improve ARDS patients’ outcome, but additional data with longer PP duration of PP are still awaited [ 8 ]. Moreover, PP increases the workload of ICU staff and is associated with certain risks, including pressure sores, potential hindrance to enteral nutrition and a higher rate of catheter-related blood stream infection [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…It was therefore recently suggested that a longer duration of prone therapy may further improve ARDS patients’ outcome, but additional data with longer PP duration of PP are still awaited [ 8 ]. Moreover, PP increases the workload of ICU staff and is associated with certain risks, including pressure sores, potential hindrance to enteral nutrition and a higher rate of catheter-related blood stream infection [ 8 ]. Those risks potentially increase with the duration of each PP session.…”
Section: Introductionmentioning
confidence: 99%
“…The mainstay of treatment for COVID-19 pneumonia includes antiviral drugs such as remdesivir ( 3 , 4 ) and anti-inflammatory drugs such as dexamethasone ( 5 , 6 ). Regarding non-pharmacological treatment of COVID-19 pneumonia, especially in critically ill patients, prone position ventilation (PPV) has shown positive results for most critical COVID-19 pneumonia patients using high-flow nasal cannula (HFNC) or invasive mechanical ventilation ( 7 - 10 ). PPV was originally introduced for severe acute respiratory distress syndrome (ARDS) ( 11 ).…”
mentioning
confidence: 99%